Proteolysis of non-phosphorylated and phosphorylated tau by thrombin
- PMID: 15542598
- DOI: 10.1074/jbc.M409234200
Proteolysis of non-phosphorylated and phosphorylated tau by thrombin
Abstract
The microtubule-associated protein tau aggregates intracellularly by unknown mechanisms in Alzheimer's disease and other tauopathies. A contributing factor may be a failure to break down free cytosolic tau, thus creating a surplus for aggregation, although the proteases that degrade tau in brain remain unknown. To address this issue, we prepared cytosolic fractions from five normal human brains and from perfused rat brains and incubated them with or without protease inhibitors. D-Phenylalanyl-L-prolylarginyl chloromethyl ketone, a thrombin-specific inhibitor, prevented tau breakdown in these fractions, suggesting that thrombin is a brain protease that processes tau. We next exposed human recombinant tau to purified human thrombin and analyzed the fragments by N-terminal sequencing. We found that thrombin proteolyzed tau at multiple arginine and lysine sites. These include Arg(155)-Gly(156), Arg(209)-Ser(210), Arg(230)-Thr(231), Lys(257)-Ser(258), and Lys(340)-Ser(341) (numbering according to the longest human tau isoform). Temporally, the initial cleavage occurred at the Arg(155)-Gly(156) bond. Proteolysis of the resultant C-terminal tau fragment then proceeded bidirectionally. When tau was phosphorylated by glycogen synthase kinase-3beta, most of these proteolytic processes were inhibited, except for the first cleavage at the Arg(155)-Gly(156) bond. Furthermore, paired helical filament tau prepared from Alzheimer's disease brain was more resistant to thrombin proteolysis than following dephosphorylation by alkaline phosphatase. The results suggest a possible role for thrombin in proteolysis of tau under physiological and/or pathological conditions in human brains. They are consistent with the hypothesis that phosphorylation of tau inhibits proteolysis by thrombin or other endogenous proteases, leading to aggregation of tau into insoluble fibrils.
Similar articles
-
Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.FEBS Lett. 2002 Oct 23;530(1-3):209-14. doi: 10.1016/s0014-5793(02)03487-7. FEBS Lett. 2002. PMID: 12387894
-
Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis.J Biol Chem. 2004 Dec 24;279(52):54518-28. doi: 10.1074/jbc.M408186200. Epub 2004 Oct 8. J Biol Chem. 2004. PMID: 15475565
-
Ser422 phosphorylation blocks human Tau cleavage by caspase-3: Biochemical implications to Alzheimer's Disease.Bioorg Med Chem Lett. 2017 Feb 1;27(3):642-652. doi: 10.1016/j.bmcl.2016.11.087. Epub 2016 Dec 2. Bioorg Med Chem Lett. 2017. PMID: 27989667
-
Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10252-7. doi: 10.1073/pnas.0703676104. Epub 2007 May 29. Proc Natl Acad Sci U S A. 2007. PMID: 17535890 Free PMC article.
-
Tau phosphorylation and aggregation in Alzheimer's disease pathology.FEBS Lett. 2006 May 22;580(12):2922-7. doi: 10.1016/j.febslet.2006.02.067. Epub 2006 Mar 3. FEBS Lett. 2006. PMID: 16529745 Review.
Cited by
-
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer's Disease.Front Aging Neurosci. 2018 Feb 6;10:27. doi: 10.3389/fnagi.2018.00027. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29472853 Free PMC article.
-
Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.Psychopharmacology (Berl). 2021 Jun;238(6):1645-1656. doi: 10.1007/s00213-021-05798-8. Epub 2021 Feb 23. Psychopharmacology (Berl). 2021. PMID: 33624157
-
It's all about tau.Prog Neurobiol. 2019 Apr;175:54-76. doi: 10.1016/j.pneurobio.2018.12.005. Epub 2018 Dec 31. Prog Neurobiol. 2019. PMID: 30605723 Free PMC article. Review.
-
Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity.Oncogene. 2008 Apr 17;27(18):2594-601. doi: 10.1038/sj.onc.1210899. Epub 2007 Oct 29. Oncogene. 2008. PMID: 17968311 Free PMC article.
-
Roles of tau protein in health and disease.Acta Neuropathol. 2017 May;133(5):665-704. doi: 10.1007/s00401-017-1707-9. Epub 2017 Apr 6. Acta Neuropathol. 2017. PMID: 28386764 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous